Posted on

Autism and disorders of aging

Podcast: Play in new window | Download

Subscribe: RSS

We have talked already about the link between autism and dementia, however a lesser known association is the one between autism and another disorder of aging: Parkinson’s Disease. A recent presentation at INSAR revealed what is known about the relationship, why they are related, what causes the association and what people with autism can do to possibly mitigate the onset of dementia and Parkinson’s Disease. Thank you to Dr. Blair Braden and Samantha Harker and Manuela Velez Galindo from the Autism and Brain Aging Lab at Arizona State University (@autismbrainaginglab @asuresearch) for joining this podcast and explaining the findings so far and what they mean for individuals and families with autism.

https://pubmed.ncbi.nlm.nih.gov/25911091

Posted on

Antidepressants do not cause autism

PlayPlay

Podcast: Play in new window | Download

Subscribe: RSS

In all the recent hype on the “overprescribing” of psychiatric medications, there is a circulating rumor antidepressant use in the mother during pregnancy has could be linked to an autism diagnosis in the child. Thankfully, there is research on this topic, and the results are clear: antidepressant exposure during pregnancy does not cause autism in children. Where would this idea come from? Early studies did show a weak link, but the association arises because there is a genetic link between having a psychiatric disorder like anxiety and stress and autism. Don’t stop taking your meds unless you discuss it with your doctor. References below:

https://pubmed.ncbi.nlm.nih.gov/42134364

https://pubmed.ncbi.nlm.nih.gov/42088678/

https://pubmed.ncbi.nlm.nih.gov/42168841/

Posted on

Lost in translation: SPARK NS helps scientists with a good idea turn it into therapies for families

Podcast: Play in new window | Download

Subscribe: RSS

SPARK – neuroscience, known to autism researchers as the other “SPARK”, is a project based out of Stanford University. This project does not collect genetics on hundreds of thousands of people, instead, they that provide funding, advice, support, mentorship, coaching and project management to scientists who have some evidence of a target in the brain relevant to autism. They help these scientists turn it into a potential drug or therapeutic that can help families. This is known as “translational research” and part of the “Valley of Death” where so many good drugs fail. This is a high-risk/high-reward endeavor. They are currently focused on therapeutics that target the functioning of the brain in autism and Parkinson’s Disease. Today’s guest is Dr. Opher Kornfeld, managing director of SPARK NS and neuroscientist. He explains how SPARK NS started, what they do, and how they have been successful helping scientists develop an idea into a potential product.

https://sparkns.org

Posted on

Somebody’s got to do it….it should someone from the autism community.

PlayPlay

Podcast: Play in new window | Download

Subscribe: RSS

In November, there will be many Congressional seats open. Wouldn’t it be great if it was someone with firsthand knowledge of the experiences of autism families and understood what they were facing? In NJ, that is happening. Dr. Samuel Wang, autism researcher and autism sibling, is running for Congress. Today’s podcast interviews Dr. Wang, why he decided to run, what he will do when elected and what he hopes to accomplish as a Congressmember. You can read more about him at www.samfornj.org

Posted on

Why is paramecetol safety so perplexing?

PlayPlay

Podcast: Play in new window | Download

Subscribe: RSS

Another study on acetaminophen (known as paramecetol in Denmark) on probability of having a child with autism, this one with over 1.5 million pregnant women, 31k who were exposed to acetaminophen. The HHS Secretary is calling it “garbage in and garbage out” because it showed no link, but in fact, it is a strong study that examined multiple confounding variables and addressed questions that had been unanswered previously. This podcast is short and so is the message: Tylenol, also known as acetaminophen or paramecetol, taken during pregnancy, does not cause autism. Period.

https://pubmed.ncbi.nlm.nih.gov/41973453

Posted on

The Mitochondria in a Minute

Podcast: Play in new window | Download

Subscribe: RSS

The word “mitochondrial deficits” gets thrown around a lot as a cause of autism, but what does this really mean? This week we interview Dr. Carisa Sirois from the University of Wisconsin, who recently published a review of how the mitochondria are involved in neurodevelopmental disorders. The ways mitochondria are involved in ASD are not simple, there are many different ways in which they affect cellular function, including genetic variations leading to impaired functioning, which then leads to brain level changes. We also discuss how the mitochondria are involved in a process called oxidative stress, which has been informally proposed to be a core process in autism.

Download the publication here:

s41583-026-01031-7Download

Posted on

Updates from I-ACC, late prematurity and language development

Podcast: Play in new window | Download

Subscribe: RSS

What is the Independent Autism Coordinating Committee and why did it meet? This week’s podcast discusses the need and the agenda of Thursday’s meeting. In addition, more research showing that epidemiologists should consider different features of autism together with prevalence numbers because they may differ across the spectrum. Finally, different types of language development are seen in those with autism, so interventions should address these differences.

https://pubmed.ncbi.nlm.nih.gov/41786477

https://pubmed.ncbi.nlm.nih.gov/41789365

https://pubmed.ncbi.nlm.nih.gov/41849261

Posted on

Rare Disease Week, the FDA, mortality in autism, trajectories and subcategories

Podcast: Play in new window | Download

Subscribe: RSS

This week’s podcast summarizes some highlights in scientific research and includes a recognition of Rare Disease Week and actions taken by the FDA to ease the criteria for evaluating genetic therapies for rare genetic disorders, the best study to date on the mortality in autism, genetic prediction of outcome in individuals with a diagnosis, and Uta Frith’s commentary on the concept of “spectrum”.

https://pubmed.ncbi.nlm.nih.gov/41773580

https://pubmed.ncbi.nlm.nih.gov/41651809

https://pubmed.ncbi.nlm.nih.gov/41661606

https://archive.ph/fPscR

Posted on

Health Care for Autistic Individuals During Transition Age

Podcast: Play in new window | Download

Subscribe: RSS

This week we talk to Dr. Emily Hotez from UCLA, (and a sibling to an autistic adult) who has focused her research on reducing stigma and marginalization, which will ultimately improve research participation to increase scientifically valid options for families. She also works on a nationwide project to improve health outcomes in autistic individuals, from birth through adulthood. Her new project focuses on chronic stress on physical health in adolescents with autism. She explains the focus of her research, the study and why it is important, and other work she is doing to improve health care in those with a diagnosis and their family members. You can read more about her study here: https://uclasharelab.org/

Posted on

Genetic pathways leading to autism

Podcast: Play in new window | Download

Subscribe: RSS

A landmark study that uses brain organoids from different people with different genes associated with autism showed that the different genes act as roads that go on different journeys to the same destination. This will be an enormously important discovery for identifying targets to treat different autism symptoms across different genetic causes of autism and understand the diversity of symptoms. Also, the new Interagency Autism Coordinating Committee was announced and there is not much breadth of perspectives.

https://www.nature.com/articles/s41586-025-10047-5